| Ticker Details |
Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp is a clinical-stage pharmaceutical company dedicated to the development of pharmaceutical products to address public health challenges. Its drug development program is focused on delivering treatment for PTSD.
|
| IPO Date: |
June 1, 2012 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$207.71M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.28 | 5.35%
|
| Avg Daily Range (30 D): |
$0.35 | 2.98%
|
| Avg Daily Range (90 D): |
$0.46 | 3.49%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.33M |
| Avg Daily Volume (30 D): |
.5M |
| Avg Daily Volume (90 D): |
.43M |
| Trade Size |
| Avg Trade Size (Sh.): |
37 |
| Avg Trade Size (Sh.) (30 D): |
76 |
| Avg Trade Size (Sh.) (90 D): |
74 |
| Institutional Trades |
| Total Institutional Trades: |
322 |
| Avg Institutional Trade: |
$1.59M |
| Avg Institutional Trade (30 D): |
$1.84M |
| Avg Institutional Trade (90 D): |
$1.62M |
| Avg Institutional Trade Volume: |
.04M |
| Avg Institutional Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$2.03M |
| Avg Closing Trade (30 D): |
$2.25M |
| Avg Closing Trade (90 D): |
$1.94M |
| Avg Closing Volume: |
51.91K |
|
|
| Financials |
| |
TTM |
Q1 2026 |
Q4 2025 |
|
Basic EPS
|
$-14.53
|
$-2.93
|
$-4.15
|
|
Diluted EPS
|
$-14.53
|
$-2.93
|
$-4.15
|
|
Revenue
|
$17.56M
|
$6.88M
|
$5.39M
|
|
Gross Profit
|
$10.28M
|
$5.3M
|
$4.33M
|
|
Net Income / Loss
|
$-147.39M
|
$-40.19M
|
$-46.91M
|
|
Operating Income / Loss
|
$-151.19M
|
$-41.54M
|
$-48.29M
|
|
Cost of Revenue
|
$7.28M
|
$1.58M
|
$1.06M
|
|
Net Cash Flow
|
$53.39M
|
$-23.8M
|
$18.46M
|
|
PE Ratio
|
|
|
|
| Splits |
|
Feb 05, 2025
|
1:100
|
|
Jun 10, 2024
|
1:32
|
|
May 10, 2023
|
4:25
|
|
May 17, 2022
|
1:32
|
|
Nov 01, 2019
|
1:10
|
|
Nov 28, 2018
|
1:10
|
|
Mar 17, 2017
|
1:10
|
|
May 01, 2013
|
1:20
|
|
|
|
